MHRA woos back clinical trials with "fair and communicative" message
This article was originally published in SRA
Executive Summary
The UK’s Medicines and Healthcare products Regulatory Agency, the MHRA, would welcome more clinical trials being performed in the UK, in the interest of promoting a research culture for the benefit of clinicians and patients.